Navigating STXBP1-related disorders: Unraveling clinical and developmental outcomes

Researchers examined the combined patient-years of seizure and developmental histories in individuals with disorders related to the STXBP1 gene.

Merck Introduces Aptegra CHO genetic stability assay for accelerated biosafety testing

Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind.

April 23, 2024

Merck’s $1.4B cyberattack suit goes to New Jersey Supreme Court

Merck’s insurance battle over $1.4 billion in alleged losses from a 2017 malware attack is now headed to New Jersey Supreme Court following an appellate

July 27, 2023

Biotech IPO raising in Q1 2024 surged from Q4 2023 – but has the momentum lasted? – Pharmaceutical Technology

Biotech initial public offerings (IPOs) surged in Q1 2024, with eight completed IPOs raising a total of $3.72bn, six times more than the $621m raised

July 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.